Rep. Grimm Urges FDA to Rule against Allowing Generic OxyContin to Hit the Market Tuesday without Abuse-Deterrent Properties

    WASHINGTON, DC – April 15, 2013 – (RealEstateRama) — Rep. Michael G. Grimm (R,C-NY) issued the following statement on the upcoming FDA ruling on allowing generic opioids, such as OxyContin and Opan, to hit the market this Tuesday

    Previous articleIf Work Brings You to the Golf Course or the Concourse, the Crowne Plaza® Hotels & Resorts Brand Will Help You on Your Way
    Next articleUSDA Proposes Simplified Application Process for Renewable Energy Funding